Insider · CIK 0001873258
Hyung Heon Kim
Files at MTVA (NeuroBo Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Hyung Heon Kim files SEC Form 4 as CEO, president and director at MTVA (NeuroBo Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Hyung Heon Kim has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | MTVA NeuroBo Pharmaceuticals, Inc. | AGrant or award Common Stock | +32,000 | $0.00 | $0 | 37,545 | Jan 27, 2026 |
| Mar 1, 2025 | MTVA NeuroBo Pharmaceuticals, Inc. | FTax withholding Common Stock | -2,795 | $1.46 | $4,081 | 61,004 | Mar 4, 2025 |
| Nov 30, 2024 | MTVA NeuroBo Pharmaceuticals, Inc. | FTax withholding Common Stock | -2,867 | $2.55 | $7,311 | 63,799 | Dec 2, 2024 |
Questions about Hyung Heon Kim
Answered from the filings on this page, as of the latest one.
Is Hyung Heon Kim buying or selling?
Hyung Heon Kim has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Hyung Heon Kim's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hyung Heon Kim has 0.
Where does Hyung Heon Kim file Form 4?
Hyung Heon Kim has filed Form 4 at MTVA (NeuroBo Pharmaceuticals, Inc.) as CEO & President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.